Clinical trial
Safety and Efficacy of Lansoprazole 30mg Twice Daily in Treatment of Laryngitis…
NCT00369265 · American Institute for Voice and Ear Research, Other · Terminated
Key facts
| NCT number | NCT00369265 |
|---|---|
| Title | Safety and Efficacy of Lansoprazole 30mg Twice Daily in Treatment of Laryngitis Associated With Gastroesophageal Reflux |
| Official title | A Randomized, Placebo-Controlled Assessment of Lansoprazole 30 mg Bid in the Treatment of Gastroesophageal Reflux Associated With Laryngitis |
| Lead sponsor | American Institute for Voice and Ear Research, Other |
| Status | Terminated |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Laryngopharyngeal Reflux |
| Intervention type | Dietary Supplement, Drug |
| Interventions | Lansoprazole, Sugar pill |
| Enrollment | 18 |
| Start date | Aug 1, 2006 |
| Primary completion | Nov 1, 2009 |
| Completion | Nov 1, 2009 |
| First posted | Aug 29, 2006 |
| Last update posted | Aug 24, 2012 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: